Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Other Non-Current Assets (2022 - 2023)

Universe Pharmaceuticals' Other Non-Current Assets history spans 2 years, with the latest figure at $35864.0 for Q3 2023.

  • For Q3 2023, Other Non-Current Assets fell 98.53% year-over-year to $35864.0; the TTM value through Sep 2023 reached $35864.0, down 98.53%, while the annual FY2023 figure was $35864.0, 98.53% down from the prior year.
  • Other Non-Current Assets for Q3 2023 was $35864.0 at Universe Pharmaceuticals, down from $2.4 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $2.4 million in Q3 2022 and bottomed at $35864.0 in Q3 2023.